-transparent.png){kind=logo}
Seven adult patients with advanced lymphoma, resistant to vincristine, prednisone, alkylating agents and Adriamycin were treated with "high dose" methotrexate and citrovorum factor rescue. Therapy consisted of 4 to 6-hour infusions of methotrexate (5--100 mg/kg) every 1 to 2 weeks with citrovorum rescue initiates 2 to 12 hours after termination of the infusion. Objective responses were obtained in three patients but these were short lived. Mucosal and hematologic toxicity occurred when repeat courses of therapy were administered. The results suggest that high dose methotrexate may be effective therapy in lymphoma, particularlly if citrovorum factor rescue is used early and in adequate dosage.
S Turman, and
M Coleman, and
R T Silver, and
M Pasmantier
December 1977,
Cancer treatment reports,
S Turman, and
M Coleman, and
R T Silver, and
M Pasmantier
September 1980,
Harefuah,
S Turman, and
M Coleman, and
R T Silver, and
M Pasmantier
January 1980,
Therapeutic drug monitoring,
S Turman, and
M Coleman, and
R T Silver, and
M Pasmantier
August 1984,
Onkologie,
S Turman, and
M Coleman, and
R T Silver, and
M Pasmantier
June 1985,
Cancer,
S Turman, and
M Coleman, and
R T Silver, and
M Pasmantier
October 1979,
Cancer research,
S Turman, and
M Coleman, and
R T Silver, and
M Pasmantier
February 1978,
Cancer treatment reports,
S Turman, and
M Coleman, and
R T Silver, and
M Pasmantier
July 1977,
Cancer treatment reports,
S Turman, and
M Coleman, and
R T Silver, and
M Pasmantier
January 1979,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
S Turman, and
M Coleman, and
R T Silver, and
M Pasmantier
March 1978,
Cancer treatment reports,
